GGrantIndex
← Leaderboards

Aloysius John Klingelhutz

University Of Iowa

$4,574,727
Attributed
$4,993,664
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $687.9K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,993,664 · 7

By mechanism

R01$2,502,120 · 2
P42$1,653,669 · 3
R21$837,875 · 2

Top collaborators

Most similar at University Of Iowa

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsTissuesIn VitroAffectBiological ModelsResearch PersonnelProgramsToxic EffectPathway InteractionsTelomeraseFunctional DisorderPlayCell LineResponseChronicCell TypeIn VivoMutantGenesDown-RegulationSiteCell TransformationCancer CellInsight

Grant awards (19)

The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome$338,756
P42 · FY2025 · ES · contact PI
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome$248,663
P42 · FY2024 · ES · contact PI
The role of ISG15 and ISGylation in the senescence-associated secretory phenotype$427,625
R21 · FY2023 · AG · contact PI
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome$260,301
P42 · FY2023 · ES · contact PI
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome$260,536
P42 · FY2022 · ES · contact PI
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome$260,537
P42 · FY2021 · ES · contact PI
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome$284,876
P42 · FY2020 · ES · contact PI
A Human Model for Telomerase Dysfunction and Aging$257,443
R01 · FY2011 · AG · contact PI
A Human Model for Telomerase Dysfunction and Aging$267,855
R01 · FY2010 · AG · contact PI
Novel Chimeric RNA Aptamer Technology to Treat Head and Neck Cancer$222,750
R21 · FY2010 · DE · contact PI
A Human Model for Telomerase Dysfunction and Aging$270,579
R01 · FY2009 · AG · contact PI
Novel Chimeric RNA Aptamer Technology to Treat Head and Neck Cancer$187,500
R21 · FY2009 · DE · contact PI
A Human Model for Telomerase Dysfunction and Aging$270,598
R01 · FY2008 · AG · contact PI
A Human Model for Telomerase Dysfunction and Aging$274,993
R01 · FY2007 · AG · contact PI
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS$220,500
R01 · FY2004 · AG
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS$220,500
R01 · FY2003 · AG
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS$220,500
R01 · FY2002 · AG
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS$250,111
R01 · FY2001 · AG
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS$249,041
R01 · FY2000 · AG